European Commission Approves VYVGART SC for Generalized Myasthenia Gravis
European Commission Gives Green Light to VYVGART SC with ENHANZE for Generalized Myasthenia Gravis In a groundbreaking move, the European ...
Tag: HALO
European Commission Grants Approval for Subcutaneous Version of VYVGART as Treatment for Generalized Myasthenia Gravis gMG
As of November 17, 2023, the European Commission has granted its approval for VYVGART® SC, a subcutaneous version of efgartigimod ...
Halozyme Therapeutics Reports Strong Q3 2023 Earnings and Positive Revenue Outlook
Halozyme Therapeutics, a leading biotechnology company, has recently released its Q3 2023 earnings report, providing valuable insights into its financial ...
Halozyme Therapeutics Expects Impressive Growth in 2023
Halozyme Therapeutics, Inc. is thrilled to announce an upward revision of its 2023 Non-GAAP Diluted EPS guidance, now projected to ...
Analyst Reaffirms Buy Rating and Sets 50 Price Target for Halozyme Therapeutics NASDAQ HALO
On October 20, 2023, Robert Wasserman, a respected analyst at Benchmark, expressed his optimistic outlook on Halozyme Therapeutics (NASDAQ:HALO). Wasserman ...
Occidental Petroleums Stock Surges Amidst Escalating IsraelHamas Conflict
As of October 9, 2023, Occidental Petroleum is experiencing a surge in its stock price, which can be attributed to ...
Pacer Advisors Inc. Increases Stake in Halozyme Therapeutics, Showing Confidence in Strong Financial Performance
On September 28, 2023, it was reported that Pacer Advisors Inc. significantly increased its stake in Halozyme Therapeutics, Inc. (NASDAQ: ...
Eaton Co. plc: A Promising Investment with Strong Earnings Growth and Shareholder Value Creation
On September 28, 2023, Members Trust Co announced its acquisition of a new position in shares of Eaton Co. plc ...
First Trust Direct Indexing L.P. Demonstrates Confidence in Halozyme Therapeutics’ Potential for Growth and Success
First Trust Direct Indexing L.P., an investment management firm, has recently increased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by ...
New Mexico Retirement Board Increases Stake in Penumbra, Inc. as Company Beats Earnings Expectations
New Mexico Educational Retirement Board has increased its stake in Penumbra, Inc. (NYSE:PEN) by 13.0% during the second quarter of ...